THE SOLUBLE FORM OF ALZHEIMERS AMYLOID-BETA PROTEIN IS COMPLEXED TO HIGH-DENSITY-LIPOPROTEIN-3 AND VERY HIGH-DENSITY-LIPOPROTEIN IN NORMAL HUMAN PLASMA

被引:134
作者
KOUDINOV, A
MATSUBARA, E
FRANGIONE, B
GHISO, J
机构
[1] NYU,MED CTR,DEPT PATHOL,NEW YORK,NY 10016
[2] VA ENGELHARDT MOLEC BIOL INST,MOSCOW B334,RUSSIA
关键词
D O I
10.1006/bbrc.1994.2788
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The amyloid fibrils of Alzheimer's neuritic plaques and cerebral blood vessels are mainly composed of aggregated forms of a 39 to 44 amino acids peptide, named amyloid beta (A beta). A similar although soluble form of A beta (sA beta) has been identified in plasma, cerebrospinal fluid and cell culture supernatants, indicating that it is produced under physiologic conditions. We report here that sA beta in normal human plasma is associated with lipoprotein particles, in particular to the HDL(3) and VHDL fractions where it is complexed to ApoJ and, to a lesser extent, to ApoAl. This was assessed by immunoprecipitation experiments of purified plasma lipoproteins and lipoprotein-depleted plasma and confirmed by means of amino acid sequence analysis. Moreover, biotinylated synthetic peptide A beta(1-40) was traced in normal human plasma in in vitro experiments. As in the case of sA beta, biotinylated A beta(1-40) was specifically recovered in the HDL(3) and VHDL fractions. This data together with the previous demonstration that A beta(1-40) is taken up into the brain via a specific mechanism and possibly as an A beta(1-40)-ApoJ complex indicate a role for HDL(3)- and VHDL-containing ApoJ in the transport of the peptide in circulation and suggest their involvement in the delivery of sA beta across the blood-brain barrier. (C) 1994 Academic Press, Inc.
引用
收藏
页码:1164 / 1171
页数:8
相关论文
共 27 条
  • [1] SOLUTION CONFORMATIONS AND AGGREGATIONAL PROPERTIES OF SYNTHETIC AMYLOID BETA-PEPTIDES OF ALZHEIMERS-DISEASE - ANALYSIS OF CIRCULAR-DICHROISM SPECTRA
    BARROW, CJ
    YASUDA, A
    KENNY, PTM
    ZAGORSKI, MG
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1992, 225 (04) : 1075 - 1093
  • [2] BURDICK D, 1992, J BIOL CHEM, V267, P546
  • [3] INVITRO FORMATION OF AMYLOID FIBRILS FROM 2 SYNTHETIC PEPTIDES OF DIFFERENT LENGTHS HOMOLOGOUS TO ALZHEIMERS-DISEASE BETA-PROTEIN
    CASTANO, EM
    GHISO, J
    PRELLI, F
    GOREVIC, PD
    MIGHELI, A
    FRANGIONE, B
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1986, 141 (02) : 782 - 789
  • [4] SANDWICH ELISA ASSAY FOR QUANTITATIVE MEASUREMENT OF SP-40,40 IN SEMINAL PLASMA AND SERUM
    CHOI, NH
    TOBE, T
    HARA, K
    YOSHIDA, H
    TOMITA, M
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1990, 131 (02) : 159 - 163
  • [5] Dergunov A D, 1991, Biokhimiia, V56, P1312
  • [6] DESILVA HV, 1990, J BIOL CHEM, V265, P13240
  • [7] GHISO J, 1993, BIOCHEM J, V293, P27, DOI 10.1042/bj2930027
  • [8] UNIFYING FEATURES OF SYSTEMIC AND CEREBRAL AMYLOIDOSIS
    GHISO, J
    WISNIEWSKI, T
    FRANGIONE, B
    [J]. MOLECULAR NEUROBIOLOGY, 1994, 8 (01) : 49 - 64
  • [9] EPITOPE MAP OF 2 POLYCLONAL ANTIBODIES THAT RECOGNIZE AMYLOID LESIONS IN PATIENTS WITH ALZHEIMERS-DISEASE
    GHISO, J
    WISNIEWSKI, T
    VIDAL, R
    ROSTAGNO, A
    FRANGIONE, B
    [J]. BIOCHEMICAL JOURNAL, 1992, 282 : 517 - 522
  • [10] AMYLOID BETA-PEPTIDE IS PRODUCED BY CULTURED-CELLS DURING NORMAL METABOLISM
    HAASS, C
    SCHLOSSMACHER, MG
    HUNG, AY
    VIGOPELFREY, C
    MELLON, A
    OSTASZEWSKI, BL
    LIEBERBURG, I
    KOO, EH
    SCHENK, D
    TEPLOW, DB
    SELKOE, DJ
    [J]. NATURE, 1992, 359 (6393) : 322 - 325